Researchers at Boston University have identified a distinctive metabolic fingerprint in people who live past 100, a discovery that could reshape how doctors approach aging and disease prevention.
The study analyzed blood samples from 213 participants, including 70 centenarians and their adult children, comparing their metabolic profiles against age-matched controls. Using advanced molecular screening to measure roughly 1,495 small molecules in the bloodstream, scientists found that people reaching extreme old age shared unusual patterns of bile acids and steroid levels that set them apart from typical aging profiles.
The metabolic signatures were not simply markers of time passing. Instead, they appear connected to biological pathways that protect against age-related disease and decline. When researchers tracked how long study participants survived after blood collection, those with these distinctive patterns showed lower mortality risk.
Genetics and lifestyle both shape longevity, with research suggesting genetics accounts for roughly half the equation in reaching 100 years old. Diet, physical activity, and social connection round out the rest. But until now, scientists had mapped immune changes in centenarians more clearly than the metabolic shifts underlying their durability.
Stefano Monti, a professor at the school leading the research, said the findings could eventually become practical tools. "If we can understand those fingerprints, we may identify biological pathways that could contribute to protecting people from age-related decline," he explained.
The team validated their results by cross-referencing their data with four separate metabolomics studies, both with and without long-lived populations, to ensure the signals held up across different research populations. They also built a machine-learning model that estimates biological age from metabolite levels, revealing whether people were aging faster or slower than their calendar years suggested. Participants whose biological age lagged behind their chronological age had better survival odds.
Several metabolic pathways emerged as candidates for future investigation, including bile acid signaling, NAD-related processes, gut bacterial metabolites, and oxidative stress markers. Any of these could become targets for new therapies or dietary interventions designed to extend healthy years.
Monti cautioned that this study's design cannot prove cause and effect. The findings need validation in larger, more diverse populations before moving toward clinical application. Still, the research team's goal is clear: translate these metabolic insights into blood tests and safe interventions that keep people active and independent longer.
The work appears in the journal GeroScience and represents one of the largest investigations of exceptionally long-lived people in North America, drawing from the New England Centenarian Study led by Thomas Perls.
Author Jessica Williams: "A blood test that predicts who will age well could revolutionize preventive medicine, but only if researchers can move from observation to intervention without overselling premature findings."
Comments